BioSymetrics to Present at MedTech Showcase™ 2019 in San Francisco
December 18, 2018 09:02 AM Eastern Time
NEW YORK—BioSymetrics Inc., a biomedical AI company, today announced that Dr. Gabe Musso, Chief Scientific Officer, will present at MedTech Showcase™ 2019 to be held January 7-9 during JP Morgan healthcare conference. The schedule is as follows:
Date: Wednesday, January 9, 2019
Time: 10:15 AM Pacific Time
Location: Parc 55 San Francisco Union Square, 55 Cyril Magnin Street, Powell-1 (Level 3)
“We’ve built AI technology that’s designed to take multiple types of biomedical data in concert, process it concurrently, and enable users to build automated workflows and tackle their most difficult data science challenges. Our framework normalizes unstructured and siloed data for scalable end-to-end machine learning,” said BioSymetrics CSO Gabe Musso.
Dr. Musso will also be available to hold one-on-one meetings with corporate partners and investors. The BioSymetrics technology offering is a SaaS-based Machine Learning (ML) platform, Augusta™, which can carry out AI ML on combinations of clinical, genomics, precision medicine, lab testing, R&D and healthcare data. Leveraging the Augusta platform is especially relevant for drug discovery applications and big data, and can yield powerful insights for biopharma and healthcare organizations.
“We are delighted that BioSymetrics will be presenting at MedTech Showcase this year,” added Sara Demy-Colton, CEO of Demy-Colton. “The conference is the perfect forum for life sciences and health technology companies to showcase innovation, and seek out their next investment or collaboration.”
Follow Biotech and MedTech Showcase on Twitter: #BTS19 #JPM19 – @EBDGroup and @Demy_Colton